House lawmakers on both sides of the Congressional aisle want federal agencies to get their act together to reduce illegal Rx drug importation. Backed by a GAO report that concluded that federal agencies are not positioned to stem the flow of imported drugs, the Congressmen blasted the FDA, DEA, and the Bureau of Customs and Border Protection representatives for failed policies and are planning a legislative fix instead.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.